Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 40
Filtrar
Más filtros












Intervalo de año de publicación
1.
Int. j. morphol ; 40(1): 233-241, feb. 2022. ilus
Artículo en Inglés | LILACS | ID: biblio-1385574

RESUMEN

SUMMARY: This study aims to investigate the effect of Tangzhouling on the morphological changes of Nissl bodies in the dorsal root ganglion of DM Rats. In this study, 69 rats were randomly divided into a control group (n = 10) and a model group (n = 59). The rats in the model group were randomly divided into a diabetic group (n = 11), a vitamin C group (n = 12), a low dose Tangzhouling group (n = 12), a medium dose Tangzhouling group (n = 12) and a high dose Tangzhouling group (n = 12). The dose of Tangzhouling in the low dose group was 5 times that of the adult dose, being 0.44g/kg/d. The dose of Tangzhouling in the medium dose group was 10 times that of the adult dose, being 0.88g/kg/d. The dose of Tangzhouling in the high dose group was 20 times that of the adult dose, being 1.75g/kg/d. All doses above are crude drug dosages. Rats in the vitamin C group were given 10 times the dose of an adult, being, 0.05 g/ kg/d. The diabetic group and the control group were given the same amount of distilled water. Drug delivery time is 16 weeks. The dorsal root ganglion was placed in a freezing tube at the end of the experiment. The morphological changes of Nissl bodies in the dorsal root ganglion were detected by HE and Nissl staining. The study results showed that vitamin C had no significant effect on the quantity, size and nucleolus. Tangzhouling can improvee the morphology, quantity and nucleolus of Nissl bodies to a certain extent, and the high dose is better than the lower dose. Tangzhouling capsules can improve the nerve function of DM rats through Nissl bodies.


RESUMEN: Este estudio tuvo como objetivo investigar el efecto de Tangzhouling en los cambios morfológicos de los cuerpos de Nissl en el ganglio de la raíz dorsal de las ratas DM. En este estudio, 69 ratas se dividieron aleatoriamente en un grupo control (n = 10) y un grupo modelo (n = 59). Las ratas del grupo modelo se dividieron aleatoriamente en un grupo diabéticos (n = 11), un grupo vitamina C (n = 12), un grupo de dosis baja de Tangzhouling (n = 12), un grupo de dosis media de Tangzhouling (n = 12) y un grupo de dosis alta de Tangzhouling (n = 12). La dosis de Tangzhouling en el grupo de dosis baja fue 5 veces mayor que la dosis del adulto, siendo 0,44 g/kg/d. La dosis de Tangzhouling en el grupo de dosis media fue 10 veces mayor que la dosis del adulto, siendo 0,88 g/kg/d. La dosis de Tangzhouling en el grupo de dosis alta fue 20 veces mayor que la dosis del adulto, siendo 1,75 g/kg/d. Todas las dosis anteriores son dosis de fármaco crudo. Se les administró 10 veces la dosis de un adulto a las ratas del grupo vitamina C, siendo 0,05 g/kg/d. El grupo de diabéticos y el grupo de control recibieron la misma cantidad de agua destilada. El tiempo de entrega del fármaco fue de 16 semanas. El ganglio de la raíz dorsal se colocó en un tubo de congelación al final del experimento. Los cambios morfológicos de los cuerpos de Nissl en el ganglio de la raíz dorsal se detectaron mediante tinción de HE y Nissl. Los resultados del estudio mostraron que la vitamina C no tuvo un efecto significativo sobre la cantidad, el tamaño y el nucléolo. Tangzhouling puede mejorar la morfología, la cantidad y el nucléolo de los cuerpos de Nissl hasta cierto punto, y es mejor la dosis alta que la dosis baja. Las cápsulas de Tangzhouling pueden mejorar la función nerviosa de las ratas DM a través de los cuerpos de Nissl.


Asunto(s)
Animales , Ratas , Enfermedades del Sistema Nervioso Periférico , Neuropatías Diabéticas , Ganglios Espinales/efectos de los fármacos , Cuerpos de Nissl/efectos de los fármacos , Coloración y Etiquetado , Modelos Animales de Enfermedad
2.
Eur J Pharmacol ; 914: 174691, 2022 Jan 05.
Artículo en Inglés | MEDLINE | ID: mdl-34896111

RESUMEN

Hydroxy-α-sanshool (HAS) is an unsaturated fatty acid amide from Zanthoxylum bungeanum Maxim. with hypolipidemic, hypoglycemic, anti-inflammatory, and neurotrophic effects, etc. In this study, results indicated that HAS effectively ameliorated spontaneous locomotion deficit of mice induced by D-galactose (D-gal) and AlCl3 treatment in open field test. Results of Morris water maze test (MWM) showed that HAS significantly improved the spatial learning and memory ability of aging mice. Histopathological evaluations revealed that HAS markedly alleviated morphological changes and increased number of Nissl neurons in hippocampus of D-gal/AlCl3-induced Alzheimer's disease (AD)-like mice. HAS markedly reduced malondialdehyde (MDA) production, and increased the activity of antioxidative enzymes including superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and catalase (CAT), showing an inhibitory effect on oxidative stress. Furthermore, HAS treatment obviously reversed the inhibitory expressions of mRNA and protein of HO-1 and Nrf2 in the hippocampus of AD mice, suggesting that neuroprotective effects of HAS against oxidative stress might be mediated by the Nrf2/HO-1 pathway. Meanwhile, HAS significantly inhibited neuronal apoptosis by decreasing mRNA and protein expressions of Cyt-c, Bax and Caspase 3, and increasing Bcl-2 expression in the hippocampus of AD mice. These results suggest that HAS have the potential to be developed as antioxidant drug for the prevention and early therapy of AD.


Asunto(s)
Enfermedad de Alzheimer , Ácidos Grasos Insaturados/farmacología , Hemo-Oxigenasa 1/metabolismo , Proteínas de la Membrana/metabolismo , Factor 2 Relacionado con NF-E2/metabolismo , Cuerpos de Nissl , Estrés Oxidativo/efectos de los fármacos , Alcamidas Poliinsaturadas/farmacología , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/patología , Animales , Antioxidantes/farmacología , Modelos Animales de Enfermedad , Hipocampo/patología , Malondialdehído/metabolismo , Ratones , Fármacos Neuroprotectores/farmacología , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Transducción de Señal/efectos de los fármacos , Aprendizaje Espacial/efectos de los fármacos , Zanthoxylum
3.
J Diabetes Res ; 2021: 2118538, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34840987

RESUMEN

BACKGROUND: The application of nanomedicine to antiretroviral drug delivery holds promise in reducing the comorbidities related to long-term systemic exposure to highly active antiretroviral therapy (HAART). However, the safety of drugs loaded with silver nanoparticles has been debatable. This study is aimed at evaluating the effects of HAART-loaded silver nanoparticles (HAART-AgNPs) on the behavioural assessment, biochemical indices, morphological, and morphometric of the hippocampus in diabetic Sprague-Dawley rats. METHODS: Conjugated HAART-AgNPs were characterized using FTIR spectroscopy, UV spectrophotometer, HR-TEM, SEM, and EDX for absorbance peaks, size and morphology, and elemental components. Forty-eight male SD rats (250 ± 13 g) were divided into nondiabetic and diabetic groups. Each group was subdivided into (n = 8) A (nondiabetic+vehicle), B (nondiabetic+HAART), C (nondiabetic+HAART-AgNPs), D (diabetic+vehicle), E (diabetic+HAART), and F (diabetic+HAART-AgNPs). Morris water maze, Y-maze test, and weekly blood glucose levels were carried out. Following the last dose of 8-week treatment, the rats were anaesthetized and euthanized. Brain tissues were carefully removed and postfixed for Nissl staining histology. RESULTS: 1.5 M concentration of HAART-AgNPs showed nanoparticle size 20.3 nm with spherical shape. HAART-AgNPs revealed 16.89% of silver and other elemental components of HAART. The diabetic control rats showed a significant increase in blood glucose, reduced spatial learning, positive hippocampal Nissl-stained cells, and a significant decrease in GSH and SOD levels. However, administration of HAART-AgNPs to diabetic rats significantly reduced blood glucose level, improved spatial learning, biochemical indices, and enhanced memory compared to diabetic control. Interestingly, diabetic HAART-AgNP-treated rats showed a significantly improved memory, increased GSH, SOD, and number of positive Nissl-stained neurons compared to diabetic-treated HAART only. CONCLUSION: Administration of HAART to diabetic rats aggravates the complications of diabetes and promotes neurotoxic effects on the experimental rats, while HAART-loaded silver nanoparticle (HAART-AgNP) alleviates diabetes-induced neurotoxicity.


Asunto(s)
Conducta Animal/efectos de los fármacos , Cognición/efectos de los fármacos , Disfunción Cognitiva/prevención & control , Diabetes Mellitus Experimental/complicaciones , Diabetes Mellitus Tipo 2/complicaciones , Neuropatías Diabéticas/prevención & control , Hipocampo/efectos de los fármacos , Nanopartículas del Metal , Cuerpos de Nissl/efectos de los fármacos , Compuestos de Plata/farmacología , Animales , Fármacos Anti-VIH , Terapia Antirretroviral Altamente Activa/efectos adversos , Disfunción Cognitiva/etiología , Disfunción Cognitiva/fisiopatología , Disfunción Cognitiva/psicología , Neuropatías Diabéticas/etiología , Neuropatías Diabéticas/fisiopatología , Neuropatías Diabéticas/psicología , Combinación Efavirenz, Emtricitabina y Fumarato de Tenofovir Disoproxil , Hipocampo/patología , Hipocampo/fisiopatología , Locomoción/efectos de los fármacos , Masculino , Memoria/efectos de los fármacos , Prueba del Laberinto Acuático de Morris/efectos de los fármacos , Cuerpos de Nissl/patología , Ratas Sprague-Dawley
4.
Mol Med Rep ; 21(1): 320-328, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31939614

RESUMEN

Cortex Mori Radicis extract (CMR) has various pharmacological properties, such as anti­inflammatory, anti­allergic and anti­hyperglycemic effects. However, the effects and mechanisms of CMR in the neuroregeneration of diabetic peripheral neuropathy (DPN) are unclear. In the present study, the effects of CMR on neurite outgrowth of dorsal root ganglia (DRG) neurons in diabetic rats were investigated and its underlying mechanisms were explored. SD rats were subjected to a high­fat diet with low­dose streptozotocin to induce a Type II diabetes model with peripheral neuropathy. CMR was then applied for four weeks continuously with or without injection of small interfere (si)RNA targeting the transient receptor potential canonical channel 1 (TRPC1) via the tail vein. Blood glucose levels, the number of Nissl bodies, neurite outgrowth and growth cone turning in DRG neurons were evaluated. The expression of TRPC1 protein, Ca2+ influx and activation of the PI3K/AKT signaling pathway were also investigated. The results of the present study showed that CMR significantly lowered blood glucose levels, reversed the loss of Nissl bodies, induced neurite outgrowth and restored the response of the growth cone of DRG neurons in diabetic rats. CMR exerted neurite outgrowth­promoting effects by increasing TRPC1 expression, reducing Ca2+ influx and enhancing AKT phosphorylation. siRNA targeting TRPC1 in the CMR group abrogated its anti­diabetic and neuroregenerative effects, suggesting the involvement of TRPC1 in the biological effects of CMR on DPN.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Neuropatías Diabéticas/tratamiento farmacológico , Morus , Neuritas/metabolismo , Proyección Neuronal/efectos de los fármacos , Extractos Vegetales/farmacología , Animales , Glucemia/efectos de los fármacos , Calcio/metabolismo , Células Cultivadas , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/genética , Diabetes Mellitus Experimental/metabolismo , Neuropatías Diabéticas/sangre , Neuropatías Diabéticas/genética , Neuropatías Diabéticas/metabolismo , Medicamentos Herbarios Chinos/farmacología , Medicamentos Herbarios Chinos/uso terapéutico , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/crecimiento & desarrollo , Ganglios Espinales/metabolismo , Masculino , Neuritas/efectos de los fármacos , Neuritas/patología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Fosfatidilinositol 3-Quinasas/metabolismo , Fosforilación , Extractos Vegetales/uso terapéutico , Proteínas Proto-Oncogénicas c-akt/metabolismo , ARN Interferente Pequeño , Ratas , Ratas Sprague-Dawley , Transducción de Señal/efectos de los fármacos , Transducción de Señal/genética , Canales Catiónicos TRPC/genética , Canales Catiónicos TRPC/metabolismo , Regulación hacia Arriba
5.
Int J Biol Macromol ; 126: 414-426, 2019 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-30593810

RESUMEN

The aim of this study was to explore the therapeutic effect and underling mechanism of Dendrobium officinale polysaccharides (DOPS) on two well-established animal models of learning and memory disabilities. Model of estrogen deficiency caused learning and memory disability can be induced by ovariectomy in mice, and mice were injected subcutaneously with d-galactose, which can also cause cognitive decline. H&E staining and Nissl staining were employed to confirm the protective effect of DOPS on hippocampal neuron. Morris water maze test, biochemical analysis, immunohistochemistry and immunofluorescence assay were used to study the effect and underlying mechanism of DOPS on two different learning and memory impairment models. Administration of DOPS significantly improved learning and memory disability in both models. Further studies showed that DOPS could attenuate oxidative stress and reduce neuro-inflammation via up-regulating expressions of Nrf2/HO-1 pathway and inhibiting activation of astrocytes and microglia in ovariectomy- and d-galactose-induced cognitive decline. These findings suggest that DOPS have an appreciable therapeutic effect on learning and memory disabilities and its mechanism may be related to activate Nrf2/HO-1 pathway to reduce oxidative stress and neuro-inflammation.


Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Dendrobium/química , Memoria/efectos de los fármacos , Polisacáridos/farmacología , Animales , Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Proteínas de Unión al Calcio/metabolismo , Femenino , Galactosa , Proteína Ácida Fibrilar de la Glía/metabolismo , Hemo-Oxigenasa 1/metabolismo , Hipocampo/metabolismo , Hipocampo/patología , Interleucina-1beta/metabolismo , Malondialdehído/metabolismo , Trastornos de la Memoria/inducido químicamente , Trastornos de la Memoria/tratamiento farmacológico , Trastornos de la Memoria/patología , Ratones , Proteínas de Microfilamentos/metabolismo , Modelos Biológicos , Factor 2 Relacionado con NF-E2/metabolismo , Neuronas/efectos de los fármacos , Neuronas/patología , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Ovariectomía , Oxidación-Reducción , Transducción de Señal/efectos de los fármacos , Superóxido Dismutasa/sangre , Factor de Necrosis Tumoral alfa/metabolismo
6.
Med Sci Monit ; 24: 2832-2840, 2018 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-29730669

RESUMEN

BACKGROUND Worldwide, epilepsy is an important chronic neurological condition. The aim of this study was to evaluate the effects of corilagin, an ellagitannin extracted from medicinal plants, on the frequency of seizures and cognitive function in a rat model of chronic epilepsy. MATERIAL AND METHODS Chronic epilepsy was induced in male Wistar rats by intraperitoneal (IP) injection of pentylenetetrazol (PTZ) for 36 days. Corilagin, 10 mg/kg and 20 mg/kg, was injected IP into treated rats, 24 days before the start of PTZ treatment, until the end of the protocol. The effects of corilagin were assessed by the pattern of epileptic seizures; cognitive function was assessed using the Morris water maze (MWM) navigation test. The mechanism of action of corilagin was investigated by measuring cytokine levels and oxidative stress parameters, including reactive oxygen species (ROS) production, and carbonic anhydrase inhibitory (CAI) activity. Histological analysis of fixed brain tissue sections included cresyl violet acetate staining (Nissl staining) for Nissl substance in the neuronal cytoplasm. RESULTS The corilagin-treated rats, compared with the control group, showed a significantly lower rate of epileptic events, improved cognitive function, reduced level of cytokines, reduced ROS production reduced CAI activity in the brain tissues (P<0.01). Histology of the rat brain tissues study showed that corilagin treatment maintained the neuronal cellular structure and number of surviving cells compared with the control group of rats. CONCLUSIONS The findings of this study showed that corilagin reduced the frequency of seizures and improved the cognitive function in a rat model of chronic epilepsy.


Asunto(s)
Cognición , Epilepsia/tratamiento farmacológico , Epilepsia/fisiopatología , Glucósidos/uso terapéutico , Taninos Hidrolizables/uso terapéutico , Convulsiones/tratamiento farmacológico , Convulsiones/fisiopatología , Animales , Biomarcadores/metabolismo , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Encéfalo/patología , Anhidrasas Carbónicas/metabolismo , Catalasa/metabolismo , Recuento de Células , Enfermedad Crónica , Cognición/efectos de los fármacos , Citocinas/metabolismo , Modelos Animales de Enfermedad , Glucósidos/farmacología , Taninos Hidrolizables/farmacología , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Aprendizaje por Laberinto/efectos de los fármacos , Dilatación Mitocondrial/efectos de los fármacos , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Estrés Oxidativo/efectos de los fármacos , Pentilenotetrazol , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/metabolismo
7.
Neurol Res ; 39(10): 895-903, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28720038

RESUMEN

OBJECTIVE: Humanin (HN) has been identified to suppress neuron death. Gly14-HN (HNG), as a variant of HN, can decrease infarct volume after ischemia/reperfusion (I/R) injury. This study aimed to investigate the neuroprotective mechanism of HNG on global cerebral I/R (GI) in rats. METHODS: Rats were randomly divided into 13 groups: Sham group, GI groups and HNG groups. Both GI group and HNG groups included six time points (1, 3, 6, 12, 24, and 72 h). At 24 h after reperfusion, Nissl staining was used to observe positive neurons, and p-STAT3, MCL-1, SOCS3, Bax and Caspase-3 in different groups were detected by immunohistochemistry. qRT-PCR and western blot were used to evaluate the expression of STAT3, p-STAT3, MCL-1, and SOCS3. RESULTS: The immunohistochemistry also showed a significant increase in Bax (0.29 ± 0.007 vs. 0.22 ± 0.007, P < 0.01) and Caspase-3 (0.24 ± 0.02 vs. 0.18 ± 0.006, P < 0.01) in GI group compared with Sham group, while Bax (0.26 ± 0.01 vs. 0.29 ± 0.008, P < 0.01) and Caspase-3 (0.20 ± 0.008 vs. 0.24 ± 0.02, P < 0.01) were significantly decreased by HNG-treatment compared with GI group. Along with immunohistochemistry, western blot and qRT-PCR indicated that the protein and mRNA levels of STAT3, MCL-1, and SOCS3 were up-regulated after administration of HNG at six time points after global cerebral I/R in rat. CONCLUSION: HNG might exert neuroprotective effects through alleviating apoptosis and activating of SOCS3 - STAT3 - MCL-1 signal transduction pathway. Highlights (1) Cerebral ischemia led to neuronal loss in hippocampal CA1 region of rats. (2) HNG had neuroprotective effects on ischemia/reperfusion rats. (3) The protective effect of HNG might be related to the SOCS3 - STAT3 - MCL-1 pathway.


Asunto(s)
Isquemia Encefálica/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Péptidos/farmacología , Daño por Reperfusión/tratamiento farmacológico , Animales , Apoptosis/efectos de los fármacos , Apoptosis/fisiología , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patología , Caspasa 3/metabolismo , Modelos Animales de Enfermedad , Masculino , Proteína 1 de la Secuencia de Leucemia de Células Mieloides/metabolismo , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Cuerpos de Nissl/patología , ARN Mensajero/metabolismo , Distribución Aleatoria , Ratas Sprague-Dawley , Daño por Reperfusión/metabolismo , Daño por Reperfusión/patología , Factor de Transcripción STAT3/metabolismo , Transducción de Señal/efectos de los fármacos , Proteína 3 Supresora de la Señalización de Citocinas/metabolismo , Proteína X Asociada a bcl-2/metabolismo
8.
Exp Biol Med (Maywood) ; 241(14): 1559-67, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-27037280

RESUMEN

Depression is usually accompanied by neuro-inflammatory reactions. Chelidonic acid, in particular, has shown anti-inflammatory effects. The objective of this study was to evaluate the anti-depressant effects of chelidonic acid and to discuss the potential mechanisms of a forced swimming test. Chelidonic acid was administered orally once a day for 14 days. On the 14th day, chelidonic acid resulted in a significant decrease in immobility time during the forced swimming test without alteration of locomotor activity, in an open field test. Chelidonic acid also increased the number of nissl bodies in the hippocampus. Brain-derived neurotrophic factor expression and extracellular signal-regulated protein kinase phosphorylation in the hippocampus were up-regulated by the administration of chelidonic acid. Chelidonic acid administration significantly increased the mRNA expression of hippocampal estrogen receptor-ß. The levels of hippocampal interleukin (IL)-1ß, IL-6, and tumor necrosis factor-α were effectively attenuated by the administration of chelidonic acid. In addition, chelidonic acid significantly increased the levels of 5-hydroxytryptamine (serotonin), dopamine, and norepinephrine compared with those levels for the mice that were administered distilled water in the hippocampus. These results suggest that chelidonic acid might serve as a new therapeutic strategy for the regulation of depression associated with inflammation.


Asunto(s)
Factor Neurotrófico Derivado del Encéfalo/metabolismo , Piranos/farmacología , Animales , Factor Neurotrófico Derivado del Encéfalo/genética , Dopamina/metabolismo , Hipocampo/efectos de los fármacos , Hipocampo/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Masculino , Ratones , Ratones Endogámicos ICR , Neurotransmisores/metabolismo , Cuerpos de Nissl/efectos de los fármacos , Norepinefrina/metabolismo , Serotonina/metabolismo , Natación , Factor de Necrosis Tumoral alfa/metabolismo , Regulación hacia Arriba
9.
Acta Histochem ; 116(1): 79-88, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23810156

RESUMEN

Recently, our research team has reported that Tualang honey was able to improve immediate memory in postmenopausal women comparable with that of estrogen progestin therapy. Therefore the aim of the present study was to examine the effects of Tualang honey supplement on hippocampal morphology and memory performance in ovariectomized (OVX) rats exposed to social instability stress. Female Sprague-Dawley rats were divided into six groups: (i) sham-operated controls, (ii) stressed sham-operated controls, (iii) OVX rats, (iv) stressed OVX rats, (v) stressed OVX rats treated with 17ß-estradiol (E2), and (vi) stressed OVX rats treated with Tualang honey. These rats were subjected to social instability stress procedure followed by novel object recognition (NOR) test. Right brain hemispheres were subjected to Nissl staining. The number and arrangement of pyramidal neurons in regions of CA1, CA2, CA3 and the dentate gyrus (DG) were recorded. Two-way ANOVA analyses showed significant interactions between stress and OVX in both STM and LTM test as well as number of Nissl-positive cells in all hippocampal regions. Both E2 and Tualang honey treatments improved both short-term and long-term memory and enhanced the neuronal proliferation of hippocampal CA2, CA3 and DG regions compared to that of untreated stressed OVX rats.


Asunto(s)
Región CA2 Hipocampal/patología , Región CA3 Hipocampal/patología , Miel , Memoria a Corto Plazo , Psicotrópicos/administración & dosificación , Estrés Psicológico/tratamiento farmacológico , Animales , Región CA2 Hipocampal/efectos de los fármacos , Región CA3 Hipocampal/efectos de los fármacos , Corticosterona/sangre , Aglomeración , Suplementos Dietéticos , Estradiol/farmacología , Femenino , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/patología , Ovariectomía , Ratas Sprague-Dawley , Conducta Social , Estrés Psicológico/sangre
10.
Cell Mol Life Sci ; 71(10): 1961-75, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24061536

RESUMEN

Bortezomib is a reversible proteasome inhibitor used as an anticancer drug. However, its clinical use is limited since it causes peripheral neurotoxicity. We have used Sprague-Dawley rats as an animal model to investigate the cellular mechanisms affected by both short-term and chronic bortezomib treatments in sensory ganglia neurons. Proteasome inhibition induces dose-dependent alterations in the architecture, positioning, shape and polarity of the neuronal nucleus. It also produces DNA damage without affecting neuronal survival, and severe disruption of the protein synthesis machinery at the central cytoplasm accompanied by decreased expression of the brain-derived neurotrophic factor. As a compensatory or adaptive survival response against proteotoxic stress caused by bortezomib treatment, sensory neurons preserve basal levels of transcriptional activity, up-regulate the expression of proteasome subunit genes, and generate a new cytoplasmic perinuclear domain for protein synthesis. We propose that proteasome activity is crucial for controlling nuclear architecture, DNA repair and the organization of the protein synthesis machinery in sensory neurons. These neurons are primary targets of bortezomib neurotoxicity, for which reason their dysfunction may contribute to the pathogenesis of the bortezomib-induced peripheral neuropathy in treated patients.


Asunto(s)
Núcleo Celular/efectos de los fármacos , Daño del ADN/efectos de los fármacos , Ganglios Sensoriales/metabolismo , Complejo de la Endopetidasa Proteasomal/metabolismo , Inhibidores de Proteasoma/farmacología , Animales , Antineoplásicos/farmacología , Ácidos Borónicos/farmacología , Bortezomib , Núcleo Celular/fisiología , Reparación del ADN/efectos de los fármacos , Ganglios Sensoriales/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Masculino , Microscopía Confocal , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/fisiología , Complejo de la Endopetidasa Proteasomal/química , Complejo de la Endopetidasa Proteasomal/genética , Pirazinas/farmacología , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley
11.
Iran Biomed J ; 18(1): 16-22, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24375158

RESUMEN

BACKGROUND: Oleuropein is a phenolic compound which is present in the olive leaf extract. The purpose of the present study was to investigate the neuroprotective effect of oleuropein as an antioxidant agent on the substantia nigra in aged rats. METHODS: Twenty 18-month-old Wistar rats (450-550 g) were randomly divided into control and experimental groups. The experimental group received a daily single dose of 50 mg/kg of oleuropein by oral gavage for 6 months. The control group received only distilled water. All rats were sacrificed two hours after the last gavage and the brains were removed and midbrains were cut. One part of the midbrains were homogenized and centrifuged. The tissue supernatant was assayed for lipid peroxidation (LPO) and antioxidant enzyme activities. The other part of midbrains fixed and embedded in paraffin, then processed for Nissl and immunohistochemistry (IHC) staining. Data was analyzed using SPSS by t-test. Differences were considered significant for P<0.05. RESULTS: The level of LPO in midbrain of the rats was decreased significantly in the experimental group, but superoxide dismutase, catalase and glutathione peroxidase activities were increased in experimental group compared to control group (P<0.05). Morphometric analyses showed significantly that the experimental group had more neurons in substantia nigra pars compacta (SNc) either in Nissl or IHC staining when compared to control (P<0.05). CONCLUSION: The results of the present study indicate that treatment of the old rats with oleuropein reduces the oxidative damage in SNc by increasing the antioxidant enzyme activities.


Asunto(s)
Antioxidantes/farmacología , Neuronas Dopaminérgicas/metabolismo , Iridoides/farmacología , Mesencéfalo/metabolismo , Sustancia Negra/metabolismo , Envejecimiento , Animales , Antihipertensivos/farmacología , Catalasa/biosíntesis , Glutatión Peroxidasa/biosíntesis , Glucósidos Iridoides , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Fármacos Neuroprotectores/farmacología , Cuerpos de Nissl/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Distribución Aleatoria , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo , Superóxido Dismutasa/biosíntesis
12.
Eur J Pain ; 18(1): 76-85, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24038589

RESUMEN

BACKGROUND: B vitamins have been demonstrated to be effective in treating chronic pain due to peripheral nerve injury. We investigated whether B vitamins could alleviate neuropathic pain and reduce neuron injury following temporary ischaemia in a rat model of spinal cord ischaemia-reperfusion injury (SCII). METHODS: SCII was produced by transiently blocking the unilateral lumbar arteries in adult male Sprague-Dawley rats. Behavioural and neurochemical signs of neuropathic pain and spinal neuron injury were analysed with and without B vitamin treatment. RESULTS: SCII caused behavioural thermal hyperalgesia and mechanical allodynia and neurochemical alterations, including increased expression of the vanilloid receptor 1 (VR1) and induction of c-Fos, as well as activation of the astrocytes and microglial cells in the spinal cord. Repetitive systemic administration of vitamin B complex (B1/B6/B12 at 33/33/0.5 mg/kg, i.p., daily, for 7-14 consecutive days) significantly reduced thermal hyperalgesia and the increased expression of VR1 and c-Fos, as well as activation of the astrocytes and microglial cells. SCII caused a dramatic decrease of the expression of the rate-limiting enzyme glutamic acid decarboxylase-65 (GAD65), which synthesizes γ-aminobutyric acid (GABA) in the axonal terminals, and ß-III-tubulin, and also caused loss of Nissl bodies in the spinal cord. These alterations were largely prevented and rescued by the B vitamin treatment. CONCLUSIONS: These findings support the idea that the B vitamins are capable of neuroprotection and antinociception during spinal cord injury due to temporary ischaemia. Rescuing the loss of inhibitory GABAergic tone may reduce spinal central sensitization and contribute to B vitamin-induced analgesia.


Asunto(s)
Hiperalgesia/tratamiento farmacológico , Neuralgia/tratamiento farmacológico , Neuronas/efectos de los fármacos , Isquemia de la Médula Espinal/complicaciones , Complejo Vitamínico B/uso terapéutico , Animales , Western Blotting , Glutamato Descarboxilasa/metabolismo , Calor , Hiperalgesia/etiología , Inmunohistoquímica , Masculino , Actividad Motora/efectos de los fármacos , Neuralgia/etiología , Neuronas/patología , Cuerpos de Nissl/efectos de los fármacos , Estimulación Física , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Ratas , Ratas Sprague-Dawley , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/patología , Isquemia de la Médula Espinal/patología , Tubulina (Proteína)/biosíntesis , Complejo Vitamínico B/administración & dosificación
13.
Nan Fang Yi Ke Da Xue Xue Bao ; 33(9): 1332-5, 2013 Sep.
Artículo en Chino | MEDLINE | ID: mdl-24067215

RESUMEN

OBJECTIVE: To study the effect of erythropoietin (EPO) on the activities of antioxidant enzymes, namely catalase (CAT) and glutathione peroxidase (GSH-Px) in the brain tissues of aged rats. METHODS: Thirty SD rats were randomly divided into normal control, aging model, and recombinant human erythropoietin (rhEPO) treatment groups (n=10). Morris water maze was used to compare the behavioral indexes. The rats were then sacrificed to observe Nissl bodies in the hippocampal neurons with Nissl staining and test the activities of CAT and GSH-Px in the brain tissues. RESULTS: Compared with the control group, the aging rats showed significantly deteriorated learning and memory abilities (P<0.05), which were improved obviously by rhEPO treatment (P<0.05). The number of Nissl bodies in the neurons was reduced in the aging rats compared with that in the control group, and rhEPO treatment increased the number of Nissle bodies but failed to restore the control level. The aging rats also showed significantly lowered activities of CAT and GSH-Px in the brain tissue (P<0.05), which were increased significantly after rhEPO treatment (P<0.05). CONCLUSION: EPO can enhance the activities of the antioxidant enzymes in the brain tissues of aged rats to increase the antioxidant capacity and produces an anti-aging effect.


Asunto(s)
Envejecimiento , Encéfalo/enzimología , Eritropoyetina/farmacología , Animales , Catalasa/metabolismo , Epoetina alfa , Glutatión Peroxidasa/metabolismo , Aprendizaje/efectos de los fármacos , Masculino , Memoria/efectos de los fármacos , Cuerpos de Nissl/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes/farmacología
14.
Biometals ; 26(1): 43-59, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23097080

RESUMEN

Lanthanum chloride (LaCl(3)) can affect neurobehavioral development and impair cognitive abilities. The mechanism underlying LaCl(3)-induced neurotoxic effects is still unknown. The purpose of this research was to investigate the neuronal impairment induced by LaCl(3) and discuss the possible mechanism from the aspects of the alteration of glutamate level, intracellular calcium concentration ([Ca(2+)](i)), Bax, Bcl-2 and caspases expression in the hippocampus. Lactational rats were exposed to 0, 0.25, 0.50 and 1.0 % LaCl(3) in drinking water, respectively. Their offspring were exposed to LaCl(3) by parental lactation and then administrated with 0, 0.25, 0.50 and 1.0 % LaCl(3) in drinking water for 1 month. The results showed that 0.25, 0.50 and 1.0 % LaCl(3) exposure induced neuronal impairment in the hippocampus of young rat. Hippocampal glutamate level, [Ca(2+)](i) and ratio of Bax and Bcl-2 expression increased significantly after LaCl(3) exposure. Besides, LaCl(3) exposure increased GRP78, GRP94, GADD153 and p-JNK expression, promoted the activation of caspase-3, caspase-9 and caspase-12, induced PARP cleavage and caused excessive apoptosis. These results indicate that LaCl(3) increases glutamate level, [Ca(2+)](i) and ratio of Bax and Bcl-2 expression, which cause excessive apoptosis by the mitochondrial and endoplasmic reticulum stress-induced pathway, and thus neuronal damages in the hippocampus.


Asunto(s)
Calcio/metabolismo , Caspasas/metabolismo , Contaminantes Ambientales/toxicidad , Ácido Glutámico/metabolismo , Hipocampo/efectos de los fármacos , Lantano/toxicidad , Animales , Apoptosis/efectos de los fármacos , Caspasas/genética , Femenino , Expresión Génica/efectos de los fármacos , Proteínas de Choque Térmico/metabolismo , Hipocampo/citología , Hipocampo/metabolismo , Proteínas Quinasas JNK Activadas por Mitógenos/metabolismo , Masculino , Glicoproteínas de Membrana/metabolismo , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuronas/ultraestructura , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Poli(ADP-Ribosa) Polimerasa-1 , Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Ratas , Ratas Wistar , Factor de Transcripción CHOP/metabolismo , Proteína X Asociada a bcl-2/genética , Proteína X Asociada a bcl-2/metabolismo
15.
Morfologiia ; 142(5): 23-6, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-23330432

RESUMEN

The formation of trigeminal motor nucleus (TMN) was studied in the early postnatal period in 21 female Wistar rats which received the serotonin biosynthesis inhibitor para-chloro-phenylalanine at prenatal Day 16 (the period of serotoninergic system formation). It was shown that the serotonin deficit during the prenatal period in rats resulted in the changes of TMN structural organization. In the early postnatal period, the delay of neuropil development, the reduction of cell body size with the partial loss of Nissl substance in some of the neurons, the presence of degenerating neurons with the signs of hyperchromatosis in all the parts of the nucleus, especially in TMN ventromedial part, were detected. At later stages, the destruction of motoneurons became slower, though some of them had morphological abnormalities. With the increase of the postnatal age (by Day 20) the number of motor neurons decreased, apparently, as a result of the gradual intensification of cell death. Simultaneously with the motor neuron degeneration in TMN parts studied, the astrocytic gliosis was observed.


Asunto(s)
Fenclonina/administración & dosificación , Neuronas Motoras , Preñez , Serotonina/metabolismo , Núcleos del Trigémino , Animales , Muerte Celular/efectos de los fármacos , Desarrollo Embrionario/efectos de los fármacos , Femenino , Neuronas Motoras/citología , Neuronas Motoras/efectos de los fármacos , Neuronas Motoras/metabolismo , Neurópilo/efectos de los fármacos , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Embarazo , Ratas , Ratas Wistar , Antagonistas de la Serotonina/administración & dosificación , Nervio Trigémino/citología , Nervio Trigémino/efectos de los fármacos , Nervio Trigémino/crecimiento & desarrollo , Núcleos del Trigémino/citología , Núcleos del Trigémino/metabolismo
16.
Iran Biomed J ; 15(1-2): 44-50, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21725499

RESUMEN

BACKGROUND: Melatonin has receptors in substantia nigra pars compacta (SNc) and regulates development of dopaminergic (DA) neurons. This study was undertaken to determine ability of melatonin to protect SNc dopaminergic neuron loss induced by estrogen deficiency in ovariectomized rats. METHODS: Female rats were randomized into four groups of seven each: control, ethanol sham, ovariectomy (ovx) and ovx with melatonin (ovx + m). In ovx, ovaries were removed. Ovx + m group was intraperitoneally injected with melatonin for 10 days, while the ethanol sham group received only ethanol. All rats were perfused with 4% paraformaldehyde, midbrains removed, fixed and paraffin embedded, then processed for Nissl and tyrosine hydroxylase staining (IHC). Ten sections of SNc in Nissl and IHC staining were analyzed in each animal, Nissl stained and tyrosine hydroxylase (TH) immunoreactive cells were counted in five experimental groups randomly. Data was analyzed using SPSS by ANOVA and t-test. Differences were considered significant for P<0.05. RESULTS: There was less cell number in ovx compared to control and ethanol sham groups significantly (P<0.001). The ovx + m group had more cells than the ovx group in the SNc significantly (P<0.001). Furthermore, there was significant decrease of TH positive cell number in the ovx group compared to control and ethanol sham groups (P<0.05). The number of TH immunoreactive cells was higher in ovx + m compared to the ovx group (P<0.05). CONCLUSION: These findings can be compared with human and used in clinical application for prevention of DA neuron death of SNc after ovariectomy.


Asunto(s)
Dopamina/metabolismo , Melatonina/farmacología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Fármacos Neuroprotectores/farmacología , Ovariectomía , Sustancia Negra/patología , Animales , Recuento de Células , Femenino , Humanos , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Ratas , Ratas Sprague-Dawley , Sustancia Negra/efectos de los fármacos , Sustancia Negra/enzimología , Tirosina 3-Monooxigenasa/metabolismo
17.
Toxicol Sci ; 103(2): 354-61, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18319242

RESUMEN

With their widespread application in industry, agriculture, medicine, and daily life, rare earth elements (REEs) are widely used in various fields and eventually accumulated in human body. Therefore, understanding the effects of REEs on health has become more and more important. In this work, the neurotoxicity of lanthanum (La) was evaluated. Wistar rats were exposed to lanthanum chloride through oral administration at 0, 0.1, 2, and 40 mg/kg doses from gestation day 0 through 6 months of age. Experiments were carried out to reveal the effects of La exposure on brain functions from four aspects including behavioral performance, [Ca2+](i) level and the activity of Ca2+-ATPase (adenosine triphosphatase) in hippocampal cells, oxidative stress, and Nissl staining. Adverse effects were observed in 2 and 40 mg/kg dose groups and increased with dose. Morris water maze test showed that La exposure at 2 and 40 mg/kg could significantly impair the behavioral performance. (The preference for the target quadrant decreased by 16.6% and 19.4% versus control, respectively.) The neurotoxicological consequences demonstrated that the alteration in homeostasis of [Ca2+](i)/Ca2+-ATPase (the ratio of [Ca2+](i) vs. Ca2+-ATPase activity increased by 44% in rats of 40 mg/kg group), the inhibition to activities of antioxidant enzymes, and the subsequent cell damage (18% and 23% cell loss in CA3 subregion of rats in 2 and 40 mg/kg group, respectively) might be involved in the neurological adverse effects of REEs exposure.


Asunto(s)
Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Contaminantes Ambientales/toxicidad , Lantano/toxicidad , Exposición Materna/efectos adversos , Síndromes de Neurotoxicidad/etiología , Animales , Encéfalo/metabolismo , Encéfalo/fisiopatología , Química Encefálica , ATPasas Transportadoras de Calcio/metabolismo , Muerte Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Contaminantes Ambientales/sangre , Contaminantes Ambientales/farmacocinética , Femenino , Lantano/sangre , Lantano/farmacocinética , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Neuronas/patología , Síndromes de Neurotoxicidad/metabolismo , Síndromes de Neurotoxicidad/fisiopatología , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/patología , Estrés Oxidativo/efectos de los fármacos , Embarazo , Ratas , Ratas Wistar , Pruebas de Toxicidad
18.
Horm Behav ; 53(1): 112-23, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17963758

RESUMEN

Marked hippocampal changes in response to excitatory amino acid agonists occur during pregnancy (e.g. decreased frequency in spontaneous recurrent seizures in rats with KA lesions of the hippocampus) and lactation (e.g. reduced c-Fos expression in response to N-methyl-d,l-aspartic acid but not to kainic acid). In this study, the possibility that lactation protects against the excitotoxic damage induced by KA in hippocampal areas was explored. We compared cell damage induced 24 h after a single systemic administration of KA (5 or 7.5 mg/kg bw) in regions CA1, CA3, and CA4 of the dorsal hippocampus of rats in the final week of lactation to that in diestrus phase. To determine cellular damage in a rostro-caudal segment of the dorsal hippocampus, we used NISSL and Fluorojade staining, immunohistochemistry for active caspase-3 and TUNEL, and we observed that the KA treatment provoked a significant loss of neurons in diestrus rats, principally in the pyramidal cells of CA1 region. In contrast, in lactating rats, pyramidal neurons from CA1, CA3, and CA4 in the dorsal hippocampus were significantly protected against KA-induced neuronal damage, indicating that lactation may be a natural model of neuroprotection.


Asunto(s)
Diestro/fisiología , Hipocampo/fisiología , Lactancia/fisiología , Neuronas/fisiología , Animales , Caspasa 3/metabolismo , Muerte Celular/efectos de los fármacos , Femenino , Hipocampo/citología , Hipocampo/efectos de los fármacos , Ácido Kaínico/toxicidad , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores , Neurotoxinas/toxicidad , Cuerpos de Nissl/efectos de los fármacos , Ratas , Ratas Wistar
19.
J Neurosci Methods ; 132(1): 1-7, 2004 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-14687669

RESUMEN

In classical chromatolysis, Nissl bodies are initially lost centrally with subsequent progression to the periphery of the neuron. Peripheral chromatolysis has the opposite pattern; it is less common and more difficult to produce. We describe a new method for producing peripheral chromatolysis in neurons of trigeminal ganglia and dorsal root ganglia that requires only injection of large doses of lithium chloride (LiCl) for two, three or four consecutive daily doses. This method may be useful for elucidating the intraneuronal mechanisms that control the location and structure of the Nissl bodies.


Asunto(s)
Adyuvantes Inmunológicos/toxicidad , Ganglios Espinales/efectos de los fármacos , Cloruro de Litio/toxicidad , Neuronas/efectos de los fármacos , Cuerpos de Nissl/efectos de los fármacos , Ganglio del Trigémino/efectos de los fármacos , Animales , Axotomía , Femenino , Ganglios Espinales/patología , Ganglios Espinales/ultraestructura , Métodos , Microscopía Electrónica/métodos , Neuronas/patología , Neuronas/ultraestructura , Cuerpos de Nissl/patología , Ratas , Ratas Endogámicas Lew , Ganglio del Trigémino/patología , Ganglio del Trigémino/ultraestructura
20.
Mov Disord ; 17(1): 13-9, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11835434

RESUMEN

Our study aimed to determine whether riluzole, which has shown efficacy as a disease-modifying agent in amyotrophic lateral sclerosis (ALS), is neuroprotective in a marmoset model of Parkinson's disease (PD). Reduction of energy demand by riluzole could be a rational neuroprotective strategy with good tolerability. The efficacy of riluzole was evaluated in marmosets by testing its ability to reduce MPTP-induced behavioral deficits and loss of dopaminergic nigral neurons. Marmosets were divided into two groups of four animals each: animals in Group 1 were injected twice with MPTP (2 mg/kg subcutaneous) and treated with riluzole (10 mg/kg per os b.i.d.), animals in Group 2 (controls) were injected with MPTP and with the vehicle of riluzole. A third group of marmosets which did not receive MPTP or riluzole drug was introduced for neurohistopathological studies (normal animals). Marmosets treated with riluzole preserved a better motor function and neurological performance through the 26 days of assessment when compared with the controls. Histologically, there was sparing of TH- and Nissl-stained nigral neurons and of TH-stained terminals in the striatum and the putamen in the group treated with riluzole compared to the controls. We conclude that riluzole protects dopaminergic neurons and reduces behavioral deficits in a marmoset model of PD.


Asunto(s)
Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Parkinson/tratamiento farmacológico , Riluzol/uso terapéutico , 1-Metil-4-fenil-1,2,3,6-Tetrahidropiridina/efectos adversos , Animales , Conducta Animal/efectos de los fármacos , Callithrix , Modelos Animales de Enfermedad , Dopamina/metabolismo , Dopaminérgicos/efectos adversos , Femenino , Inmunohistoquímica , Locomoción/efectos de los fármacos , Masculino , Fármacos Neuroprotectores/farmacología , Cuerpos de Nissl/efectos de los fármacos , Cuerpos de Nissl/metabolismo , Cuerpos de Nissl/patología , Enfermedad de Parkinson Secundaria/inducido químicamente , Distribución Aleatoria , Riluzol/farmacología , Sustancia Negra/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...